Focus on vitamin D and the adrenal gland.
Study Goal
The researchers aimed to review the role of vitamin D in adrenal diseases and evaluate the results of vitamin D supplementation studies in patients.
Results Summary
The abstract suggests that vitamin D may have beneficial effects in adrenal diseases, including potential impacts on adrenocortical cancer cells, but emphasizes the need for more randomized controlled trials and mechanistic studies to confirm efficacy and safety.
Population
Patients with adrenal diseases, including adrenocortical cancer, type 1 and type 2 diabetes, and polycystic ovary syndrome.
Effective Dosage
Not mentioned
Duration
Not mentioned
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
vitamin D | no change | calcium and phosphorus homeostasis | - | - | maintain | #1 |
vitamin D | no change | bone health | - | - | preserving | #2 |
vitamin D | neutral | nonskeletal disorders such as endocrine diseases and in particular type 1 diabetes, type 2 diabetes, adrenal diseases, and the polycystic ovary syndrome | - | - | play a role in | #3 |
low vitamin D levels | neutral | cortisol and aldosterone overproduction | - | - | association with | #4 |
vitamin D | neutral | adrenocortical cancer cells | in vitro | - | effects | #5 |
vitamin D supplementation | neutral | adrenal diseases | patients | - | studies | #6 |
vitamin D | neutral | adrenal disease | - | - | beneficial role | #7 |
The main role of vitamin D is to maintain calcium and phosphorus homeostasis, thus preserving bone health. However, recent evidences have demonstrated that vitamin D may also play a role in a variety of nonskeletal disorders such as endocrine diseases and in particular type 1 diabetes, type 2 diabetes, adrenal diseases, and the polycystic ovary syndrome. Despite controversial results on an association of low vitamin D levels with cortisol and aldosterone overproduction, encouraging in vitro findings have been reported on vitamin D effects in adrenocortical cancer cells. The focus of this review is the role of vitamin D in adrenal diseases and the results of vitamin D supplementation studies in patients. Although many studies support a beneficial role of vitamin D in adrenal disease, randomized controlled trials and mechanistic studies are required to provide more insight into the efficacy and safety of vitamin D as a therapeutic tool.